Sponsor

Quantum Genomics SA

Clinical research sponsor

Published trials7
Recruiting shown0
Roles1
SourceClinicalTrials.gov

Clinical trials

7 shown
Randomized Study of Extended Treatment With Firibastat in Treatment-Resistant Hypertension (REFRESH)NCT04857840 · lead sponsor · 2021-08-05
TERMINATED
Firibastat in Treatment-resistant HypertensionNCT04277884 · lead sponsor · 2020-06-25
COMPLETED
Novel Evaluation With QGC001 in Hypertensive Overweight Patients of Multiple Ethnic OriginsNCT03198793 · lead sponsor · 2017-10-13
COMPLETED
QUantum Genomics Incremental Dosing in Heart Failure - QUID-HFNCT02780180 · lead sponsor · 2016-06-01
TERMINATED
Phase IIa Study of the Product QGC001 Compared With Placebo in Patients With Essential HypertensionNCT02322450 · lead sponsor · 2015-01-01
COMPLETED
Study of the Product QGC001 as a Single Dose and Multiple Doses Administered Orally to Healthy Adult SubjectsNCT01900184 · lead sponsor · 2012-12-01
COMPLETED
Phase I Study in Healthy Male Subjects Comparing QGC001 to PlaceboNCT01900171 · lead sponsor · 2012-02-01
COMPLETED

Sponsor roles

lead sponsor7

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.